La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

i-SENS Crescita futura

Future criteri di controllo 4/6

i-SENS prevede che gli utili e i ricavi cresceranno rispettivamente di 62.5% e 15.8% all'anno. Si prevede che l'EPS crescerà di 62% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 5.7% in 3 anni.

Informazioni chiave

68.7%

Tasso di crescita degli utili

68.2%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili	33.7%
Tasso di crescita dei ricavi	16.7%
Rendimento futuro del capitale proprio	3.3%
Copertura analitica	Low
Ultimo aggiornamento	23 Aug 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Aug 05

If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

Jan 18

Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Jan 05

Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

Dec 24

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 15

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Dec 02

Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Nov 20

Previsioni di crescita degli utili e dei ricavi

KOSDAQ:A099190 - Stime future degli analisti e dati finanziari passati (KRW Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	398,050	24,000	-9,800	11,150	2
12/31/2025	343,950	15,200	-5,750	14,000	2
12/31/2024	296,550	12,400	-16,200	-2,150	2
6/30/2024	280,288	-3,531	-7,855	17,760	N/A
3/31/2024	272,877	-766	-17,322	20,060	N/A
12/31/2023	265,120	3,709	-29,603	13,045	N/A
9/30/2023	255,913	4,843	-18,181	23,853	N/A
6/30/2023	257,387	7,696	-29,225	8,483	N/A
3/31/2023	256,661	7,352	-18,308	8,513	N/A
12/31/2022	264,837	16,138	-16,614	6,653	N/A
9/30/2022	262,067	20,078	-57,431	-6,215	N/A
6/30/2022	252,562	25,059	-36,348	13,431	N/A
3/31/2022	249,178	31,504	-32,860	16,847	N/A
12/31/2021	232,935	25,451	-30,970	17,224	N/A
9/30/2021	225,758	29,923	14,565	27,600	N/A
6/30/2021	217,293	29,022	18,484	30,397	N/A
3/31/2021	211,667	27,286	20,705	29,805	N/A
12/31/2020	203,708	26,839	26,611	34,615	N/A
9/30/2020	201,817	17,606	25,834	33,340	N/A
6/30/2020	199,980	19,878	33,432	39,647	N/A
3/31/2020	193,528	24,733	31,503	38,091	N/A
12/31/2019	189,844	23,426	30,331	37,951	N/A
9/30/2019	184,139	33,949	19,199	29,548	N/A
6/30/2019	181,109	32,287	12,915	21,509	N/A
3/31/2019	175,627	24,622	11,041	21,619	N/A
12/31/2018	172,997	22,619	9,006	19,543	N/A
9/30/2018	168,333	18,247	21,839	31,009	N/A
6/30/2018	162,795	15,450	16,334	27,742	N/A
3/31/2018	159,320	16,437	N/A	24,542	N/A
12/31/2017	156,964	15,730	N/A	22,376	N/A
9/30/2017	150,725	16,808	N/A	16,489	N/A
6/30/2017	144,108	18,050	N/A	13,498	N/A
3/31/2017	139,709	16,295	N/A	11,232	N/A
12/31/2016	132,468	17,561	N/A	11,727	N/A
9/30/2016	121,640	17,066	N/A	13,337	N/A
6/30/2016	113,583	15,074	N/A	15,711	N/A
3/31/2016	107,804	15,692	N/A	19,331	N/A
12/31/2015	101,921	14,716	N/A	22,559	N/A
9/30/2015	100,074	13,736	N/A	16,645	N/A
6/30/2015	97,317	14,036	N/A	22,532	N/A
3/31/2015	95,553	14,049	N/A	20,377	N/A
12/31/2014	95,608	14,466	N/A	17,845	N/A
9/30/2014	93,515	16,322	N/A	19,312	N/A
6/30/2014	91,059	18,239	N/A	15,562	N/A
3/31/2014	86,720	18,646	N/A	13,830	N/A
12/31/2013	82,863	18,642	N/A	16,190	N/A
9/30/2013	81,970	16,418	N/A	13,014	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che A099190 diventerà redditizio nei prossimi 3 anni, il che è considerato una crescita più rapida del tasso di risparmio ( 2.6% ).

Guadagni vs Mercato: Si prevede che A099190 diventerà redditizia nei prossimi 3 anni, il che è considerato una crescita superiore alla media del mercato.

Guadagni ad alta crescita: Si prevede A099190 diventerà redditizia nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di A099190 ( 15.8% all'anno) crescerà più rapidamente del mercato KR ( 10.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di A099190 ( 15.8% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di A099190 sarà basso tra 3 anni ( 5.7 %).

i-SENS Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Consensus EPS estimates fall by 40%

Price target increased by 25% to ₩27,500

Price target decreased by 9.8% to ₩39,700

Consensus forecasts updated

Consensus EPS estimates fall by 10%

Price target increased to ₩40,500

Recent updates

i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Kwang Dong Pharmaceutical Co., Ltd. (KOSE:A009290) agreed to acquire 29.7% stake in Precision Biosensor, Inc. (KOSDAQ:A335810) from i-SENS, Inc. (KOSDAQ:A099190) from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo for KRW 16.9 billion.

First quarter 2024 earnings released: ₩10.00 loss per share (vs ₩153 profit in 1Q 2023)

i-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd

i-SENS, Inc. announced that it expects to receive KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd

i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings

Full year 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of ₩175 per share at 0.7% yield

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 40%

New major risk - Revenue and earnings growth

Price target increased by 25% to ₩27,500

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 17%

Price target decreased by 9.8% to ₩39,700

Upcoming dividend of ₩300 per share

Less than half of directors are independent

Consensus forecasts updated

Consensus EPS estimates fall by 10%

Price target increased to ₩40,500

Less than half of directors are independent

Upcoming dividend of ₩250 per share

Consensus forecasts updated

Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)

Consensus forecasts updated

Investor sentiment improved over the past week

Do i-SENS's (KOSDAQ:099190) Earnings Warrant Your Attention?

Is i-SENS (KOSDAQ:099190) Using Too Much Debt?

Is i-SENS, Inc.'s (KOSDAQ:099190) 0.8% Dividend Worth Your Time?

i-SENS, Inc., Annual General Meeting, Mar 26, 2021

New 90-day low: ₩25,050

Will i-SENS (KOSDAQ:099190) Multiply In Value Going Forward?

How Much Of i-SENS, Inc. (KOSDAQ:099190) Do Insiders Own?

If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

New 90-day low: ₩26,450

Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

New 90-day high: ₩29,650

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Price target raised to ₩37,000

New 90-day high - ₩30,550

New 90-day high - ₩29,500

Price target lowered to ₩33,000

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita